- GLP studies cleared in next 2-3 weeks. This sets us up with a drug that is superior to any other FDA approved drug in a 4 billion dollar market and safety being cleared this quarter. The company will become a 100 million dollar plus company on this target market alone and NYR own and have patented the whole drug class.
Ann: Investor Presentation, page-2
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.010(8.70%) |
Mkt cap ! $22.01M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 10.5¢ | $88.72K | 828.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 272917 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 52619 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |